Cargando…
In Vivo Double Targeting of C26 Colon Carcinoma Cells and Microenvironmental Protumor Processes Using Liposomal Simvastatin
Purpose: Besides cholesterol lowering effects, simvastatin (SIM) at very high doses possesses antitumor actions. Moreover our previous studies demonstrated that tumor-targeted delivery of SIM by using long-circulating liposomes (LCL) improved the therapeutic index of this drug in murine melanoma-bea...
Autores principales: | Luput, Lavinia, Licarete, Emilia, Drotar, Denise Minerva, Nagy, Andras-Laszlo, Sesarman, Alina, Patras, Laura, Rauca, Valentin Florian, Porfire, Alina, Muntean, Dana, Achim, Marcela, Tomuta, Ioan, Vlase, Laurian, Catoi, Cornel, Dragos, Nicolae, Banciu, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771352/ https://www.ncbi.nlm.nih.gov/pubmed/29344291 http://dx.doi.org/10.7150/jca.21560 |
Ejemplares similares
-
Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo
por: Luput, Lavinia, et al.
Publicado: (2020) -
Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis
por: Negrea, Giorgiana, et al.
Publicado: (2022) -
Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression
por: Rauca, Valentin-Florian, et al.
Publicado: (2021) -
Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells
por: Rauca, Valentin-Florian, et al.
Publicado: (2018) -
Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment
por: Licarete, Emilia, et al.
Publicado: (2020)